Harvoni
List of products in the National Drug Code with proprietary name harvoni. This medication is a combination of ledipasvir and sofosbuvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" (including the use of latex condoms) to lower the risk of passing the virus to others.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
61958-1801 | Harvoni | Ledipasvir And Sofosbuvir | Tablet, Film Coated | Oral | Gilead Sciences, Inc | Human Prescription Drug |
61958-1803 | Harvoni | Ledipasvir And Sofosbuvir | Tablet, Film Coated | Oral | Gilead Sciences, Inc | Human Prescription Drug |
61958-1804 | Harvoni | Ledipasvir And Sofosbuvir | Pellet | Oral | Gilead Sciences, Inc | Human Prescription Drug |
61958-1805 | Harvoni | Ledipasvir And Sofosbuvir | Pellet | Oral | Gilead Sciences, Inc | Human Prescription Drug |